I have tested a lot of red light therapy panels over the past few years. The Mito Red Light MitoPRO 1500 and the Joovv Solo 3.0 are two of the most well-known names in this space, and I wanted to find out which one actually delivers for the price.
Both the Mito Red Light vs Joovv comparison keeps coming up in the RLT community. People want to know if the premium Joovv price tag is justified or if Mito gives you equivalent results for less.
After testing both panels in my own routine, I have a clear answer. Neither is the strongest choice available today, and I will explain why the RLT Home Total Spectrum MAX is a better option for most people.
Quick Verdict
The Mito Red Light MitoPRO 1500 wins this head-to-head comparison. It delivers exceptional irradiance at a lower price point than Joovv, with the same core wavelengths and a larger panel footprint.
Joovv has a better build and a more polished system, but the output-to-cost ratio does not justify the extra spend.
That said, both panels are limited to two wavelengths, which means neither gives you the full-spectrum coverage that newer panels provide.
For the best overall result, the RLT Home Total Spectrum MAX covers seven wavelengths, is third-party tested, and is priced more competitively than the Joovv.
Quick Verdict: Mito Red Light edges out Joovv on power output and value, but both are limited to two wavelengths. The RLT Home Total Spectrum MAX gives you seven wavelengths, third-party testing, and a better price than Joovv.
What Is Mito Red Light MitoPRO 1500
Mito Red Light is a US-based brand that launched in 2019 and built a following quickly among biohackers and strength athletes.
The MitoPRO 1500 is their flagship full-body panel, designed to compete with clinical-grade devices at a fraction of the cost.
The panel runs 300 dual-chip 5W LEDs at 660nm and 850nm wavelengths, drawing around 300W of power. It stands 36 inches tall, covers the full body in a single session, and supports modular daisy-chaining for those who want more coverage.
Read my Mito Red Light review for my experience using this red light therapy device.
Pros
- 300 dual-chip LEDs delivering exceptional irradiance
- Full-body panel at 36 inches tall
- Independent wavelength control for red and NIR separately
- Modular daisy-chain capability
- 3-year warranty with 60-day trial
- Priced lower than Joovv for more power
Cons
- Only two wavelengths (660nm and 850nm)
- Loud fan noise during operation
- Industrial look that does not suit all home setups
- Customer support has been inconsistent based on user reports
- No expanded NIR wavelengths like 810nm or 830nm
What Is Joovv Solo 3.0
Joovv is one of the original consumer red light therapy brands and has built a reputation as the premium option in the space.
The Solo 3.0 is their entry-level modular panel, designed for targeted treatment with the option to expand the system over time.
It runs at approximately 60W of power, emits 660nm and 850nm wavelengths, and features a clinical-grade anodized aluminum build. The panel dimensions are roughly 9 by 18 inches, making it a smaller device than the MitoPRO 1500.
Read my Joovv review for my experience using this red light therapy device.
Pros
- Best-in-class build quality with anodized aluminum housing
- Modular stacking system for expandable coverage
- Pulse mode for advanced light delivery protocols
- Quiet fan operation compared to industrial panels
- 3-year warranty with 60-day trial
- Strong brand reputation and established customer base
Cons
- Only two wavelengths (660nm and 850nm)
- High price relative to output
- No expanded NIR wavelengths (810nm or 830nm)
- Heavy for its size
- Limited third-party testing data publicly available
- Smaller panel area requires more session time for full-body coverage
Mito Red Light vs Joovv Solo 3.0: Main Differences
Wavelengths
Both the MitoPRO 1500 and the Joovv Solo 3.0 use 660nm and 850nm wavelengths. Research shows 660nm light supports skin cell repair and collagen production,[1] while 850nm penetrates deeper into muscle and joint tissue.[2]
Neither panel includes intermediate wavelengths like 810nm or 830nm, which limits their spectrum compared to multi-band devices.[3]
Build Quality
Joovv clearly leads on build quality. The anodized aluminum chassis and quiet fans make it feel like a clinical device.
Mito uses a powder-coated metal housing that is functional but has an industrial look and noticeably loud fans.
Irradiance And Output
The MitoPRO 1500 generates far more total output than the Joovv Solo 3.0. With 300 dual-chip 5W LEDs drawing 300W of power, it delivers higher irradiance across a larger surface area.
Joovv's Solo 3.0 draws only 60W, which means shorter effective treatment distances and longer sessions needed for equivalent dosing.[4]
Price
| Product | Price | LED Count | Wavelengths | Warranty |
|---|---|---|---|---|
| Mito Red Light MitoPRO 1500 | ~$599 | 300 dual-chip | 660nm, 850nm | 3 years / 60-day trial |
| Joovv Solo 3.0 | ~$695 | Not specified | 660nm, 850nm | 3 years / 60-day trial |
| RLT Home Total Spectrum MAX | Check site | Multi-chip array | 7 wavelengths incl. 1064nm | 3 years / 60-day trial |
Use Cases
Mito Red Light suits athletes and biohackers who want maximum irradiance for full-body sessions.
Joovv suits users who want a polished system with a modular setup they can expand over time. Neither is ideal for someone wanting full-spectrum wavelength coverage in a single panel.
My Experience Using Mito Red Light And Joovv
I started with the Joovv Solo 3.0 and used it daily for six weeks, targeting my lower back and shoulders. The build quality impressed me immediately. It was easy to mount, ran quietly, and felt like a quality piece of equipment.
After six weeks I switched to the MitoPRO 1500. The difference in panel size and heat output was noticeable from the first session.
I could stand three feet back and still feel the output clearly. Recovery after heavy training sessions felt similar across both panels, which is consistent with what the two-wavelength overlap would suggest.
Where Mito pulled ahead was in practical value. I was getting more coverage per session, the full-body footprint meant I did not have to reposition between upper and lower body, and the price was lower.
Joovv felt like I was paying for the name and the chassis design rather than meaningfully better results.
The limitation with both became clear after I started testing seven-wavelength panels. The expanded wavelengths, especially 810nm and 1064nm, felt different in deep tissue sessions.
Both the Mito and Joovv delivered solid results, but the wavelength ceiling was real.
Should You Buy Mito Red Light Or Joovv
If you are choosing strictly between these two, Mito Red Light is the better buy. You get more power, a larger panel, and a lower price tag.
The Joovv Solo 3.0 is a well-built device, but its output does not justify the price premium for most users.
Joovv makes sense for someone who wants a modular system and plans to stack multiple panels over time.
The build quality and pulse mode are genuine advantages for clinic-style users who care about aesthetics and system design.
That said, both devices share the same fundamental limitation: two wavelengths. If you want the broadest spectrum coverage, including the 1064nm deep near-infrared wavelength that is not available on either panel, the RLT Home Total Spectrum MAX is the strongest overall choice. It is third-party tested, covers seven wavelengths, and is priced better than the Joovv.
References
- Avci P, et al. Low-level laser (light) therapy (LLLT) in skin: stimulating, healing, restoring. Semin Cutan Med Surg. 2013;32(1):41-52. https://pubmed.ncbi.nlm.nih.gov/24049929/
- Leal Junior EC, et al. Effect of 830 nm low-level laser therapy in exercise-induced skeletal muscle fatigue in humans. Lasers Med Sci. 2010;25(2):229-36. https://pubmed.ncbi.nlm.nih.gov/19005739/
- Chung H, et al. The nuts and bolts of low-level laser (light) therapy. Ann Biomed Eng. 2012;40(2):516-33. https://pubmed.ncbi.nlm.nih.gov/22045511/
- Hamblin MR. Mechanisms and mitochondrial redox signaling in photobiomodulation. Photochem Photobiol. 2018;94(2):199-212. https://pubmed.ncbi.nlm.nih.gov/29164625/